Dr. Reddy’s arm receives communication from Regulatory Authority of Germany

10 Aug 2017 Evaluate

Dr. Reddy’s Laboratories’ wholly-owned subsidiary -- betapharm Arzneimittel GmbH, Germany has received a communication from the Regulatory Authority of Germany (Regierung von Oberbayern), that the GMP compliance certificate in respect of the company's Formulations Manufacturing Unit 2 plant in Bachupally, Hyderabad is not renewed consequent to the recent inspection of the plant. Pending revocation of the non-compliance notification, the plant will not be able to make any further despatch to the European Union until the next inspection, to be initiated by an invitation from betapharm.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1318.75 -6.75 (-0.51%)
12-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.00
Dr. Reddys Lab 1318.75
Cipla 1325.25
Zydus Lifesciences 916.55
Lupin 2356.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×